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Reprogramming differentiated cells into induced
pluripotent stem cells (iPSCs) promotes a broad array
of cellular changes. Here we show that the let-7
family of microRNAs acts as an inhibitory influence
on the reprogramming process through a regula-
tory pathway involving prodifferentiation factors,
including EGR1. Inhibiting let-7 in human cells pro-
motes reprogramming to a comparable extent to
c-MYC when combined with OCT4, SOX2, and KLF4,
and persistence of let-7 inhibits reprogramming.
Inhibiting let-7 during reprogramming leads to an in-
crease in the level of the let-7 target LIN-41/TRIM71,
which in turn promotes reprogramming and is
important for overcoming the let-7 barrier to reprog-
ramming. Mechanistic studies revealed that LIN-41
regulates a broad array of differentiation genes, and
more specifically, inhibits translation of EGR1 through
binding its cognate mRNA. Together our findings
outline a let-7-based pathway that counteracts the
activity of reprogramming factors through promoting
the expression of prodifferentiation genes.
INTRODUCTION
Fibroblasts can be reprogrammed into cells remarkably similar
to embryonic stem cells (ESCs) by the expression of OCT4,
SOX2, and KLF4 (OSK), with or without c-MYC (M) (Maherali
et al., 2007; Meissner et al., 2007; Nakagawa et al., 2008; Okita
et al., 2007; Park et al., 2008; Takahashi et al., 2007; Takahashi
and Yamanaka, 2006; Wernig et al., 2007, 2008). Like ESCs,
these reprogrammed cells, called induced pluripotent stem cells
(iPSCs), can give rise to almost all cellular lineages upon differen-
tiation. While it is known that OSKM induces genome-wide tran-
scriptional changes that result in conversion to iPSCs, less is
understood about the downstream events after reprogramming
initiation. Furthermore, the efficiency of conversion with OSKM
is very low (typically less than 1%). Without M, reprogramming40 Cell Stem Cell 14, 40–52, January 2, 2014 ª2014 Elsevier Inc.efficiency is even lower (Nakagawa et al., 2008; Wernig et al.,
2008). A few barriers contributing to low reprogramming effi-
ciency have been described, including H3K9 methylation
(Chen et al., 2013), macroH2A (Gaspar-Maia et al., 2013; Pasque
et al., 2012), and upregulation of p53, p21, and p16Ink4a triggered
by reprogramming factors (reviewed in Banito and Gil, 2010).
Recent reports indicate that MBD3 of the NuRD complex is
also a significant barrier to reprogramming (Luo et al., 2013;
Rais et al., 2013).
We hypothesized that microRNAs (miRNAs) abundant in fibro-
blasts, but not expressed in iPSCs and ESCs, may also be a
reprogramming barrier. One candidate was the let-7 family of
miRNAs, since it is abundant in differentiated cells and low in
pluripotent stem cells (Newman et al., 2008; Rybak et al., 2008;
Viswanathan et al., 2008). Supporting this hypothesis, let-7 regu-
lates differentiation inCaenorhabditis elegans, where loss of let-7
results in reiteration of larval cell fates and overexpression results
in precocious expression of adult fates (Hunter et al., 2013;
Reinhart et al., 2000). Also, let-7 is downregulated in many types
of cancer (reviewed in Boyerinas et al., 2010), consistent with a
role in promoting a differentiated state. Therefore, since let-7
has been shown to promote differentiation, we thought it might
also be a barrier to reprogramming to pluripotency.
In addition, let-7 is regulated by another heterochronic gene,
LIN-28, which has also been shown to promote human reprog-
ramming with the OS+NANOG cocktail of factors (Yu et al.,
2007). LIN-28 binds and blocks maturation of the primary and
precursor let-7 transcripts (reviewed in Mayr and Heinemann,
2013). LIN-28 is abundantly expressed in pluripotent stem cells
and is downregulated as cells differentiate, whereas mature
let-7 levels rise as cells differentiate in mice and humans (New-
man et al., 2008; Rybak et al., 2008; Viswanathan et al., 2008).
let-7 has been implicated in the regulation of reprogramming in
mice, as antagonizing let-7 with OSK in mouse embryonic
fibroblasts (MEFs) containing an Oct4-GFP reporter induced
GFP-positive colonies (Melton et al., 2010). However, the effect
of let-7 on human iPSC generation has not been previously
examined. In addition, while let-7 targets have been identified
in studies of ESCs lacking miRNA processing machinery (Melton
et al., 2010), cancer (Johnson et al., 2007; Kumar et al., 2007; Lee
and Dutta, 2007; Mayr et al., 2007; Sampson et al., 2007), and
development (Johnson et al., 2005; Slack et al., 2000), targets
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fied experimentally.
In this study, we found that let-7 is a barrier to human iPSC re-
programming. Combining OSK transduction with let-7 inhibition
in human dermal fibroblasts (HDFs) improved reprogramming
efficiency, similar to OSKM, and yielded a larger percentage of
colonies with true ESC-like morphology compared to OSKM.
Prolonged expression of let-7 blocked reprogramming. Further-
more, we identified the let-7 target LIN-41 (also known as
TRIM71 and Mlin41) as a key factor that is necessary to over-
come the let-7 barrier to reprogramming. LIN-41 is also a heter-
ochronic gene that has been linked to translational regulation
in mammals and C. elegans. Overexpression of LIN-41 in
C. elegans results in reiteration of larval fates, and loss of LIN-
41 results in precocious differentiation, the opposite effect of
let-7 (Reinhart et al., 2000; Slack et al., 2000). We found that
LIN-41 regulates expression of genes involved in development
and differentiation in its capacity as a reprogramming factor.
Finally, we identified the prodifferentiation transcription factor
EGR1 (also known as NGFI-A, KROX-24, ZIF268, and TIS8) as
a direct target of posttranscriptional regulation by LIN-41 and
showed that it also inhibits reprogramming. Thus, we have iden-
tified a regulatory pathway downstream of let-7 that acts as a
barrier to reprogramming by promoting the expression of prodif-
ferentiation genes.
RESULTS
Inhibiting let-7 Promotes Efficiency and Quality of
Human iPSC Reprogramming
Consistent with documented results, we observed that the levels
of let-7 miRNAs are high in fibroblasts and low in pluripotent
stem cells (Figure S1A available online and Newman et al.,
2008; Rybak et al., 2008; Viswanathan et al., 2008). To determine
if antagonizing let-7 activity promotes reprogramming of HDFs
to iPSCs, we transfected let-7 or control antisense inhibitors
(inh) during reprogramming with OSK or OSKM. Inhibiting let-7
increased the efficiency of OSK-induced reprogramming by
one or two orders of magnitude, similar to that observed with
OSKM (Figures 1A and S1B). In Oct4-GFP reporter MEFs, let-7
inh was previously found to boost production of colonies
by about 4-fold (Melton et al., 2010). Transfecting let-7 inh
with OSKM increased reprogramming efficiency by only about
2-fold over control inh, which itself slightly increased reprogram-
ming efficiency, as reported for MEFs (Figures 1A and S1B and
Melton et al., 2010).
Reprogramming with OSKM produces colonies of which most
fail to develop ES-like morphology or become true iPSCs (Fig-
ure 1B). In contrast, the vast majority of colonies reprogrammed
with OSK+let-7 inh had ES-like morphology and were TRA-1-
60+ (90%, OSK+let-7 inh, versus 40%, OSKM) (Figure 1B and
S1C and data not shown).
Repeated transfections and starting let-7 inhibition early led to
the highest number of colonies, which decreasedwith increasing
delay in initiating inhibition (Figure S1D). The greatest improve-
ments in reprogramming efficiency depend on antagonizing
let-7 throughout reprogramming (Figure S1D).
We found that inhibiting let-7 during reprogramming slightly
increased the number of cells (Figure S1E), consistent withstudies showing a role for let-7 in cell-cycle regulation (Dong
et al., 2010; Johnson et al., 2005, 2007; Lee and Dutta, 2007;
Legesse-Miller et al., 2009; Mayr et al., 2007). However, this
minor increase in cell number is unlikely to account for the one
to two orders of magnitude by which reprogramming was
increased due to let-7 inhibition. We conclude that let-7’s re-
programming-enhancing effects aremost significantly attributed
to its direct effects on reprogramming rather than acceleration of
cell proliferation, consistent with data showing that let-7 inhibi-
tion did not enhance MEF proliferation (Melton et al., 2010).
We picked iPSC colonies derived from the OSK+let-7
inh cocktail and expanded them for further characterization.
They expressed pluripotency markers, had normal karyotypes,
formed teratomas with all three embryonic germ layers in vivo,
and differentiated into derivatives of all three embryonic germ
cell lineages in vitro (Figures 1C and S2A–S2C).
To test if high let-7 levels inhibit reprogramming, we trans-
fected cells with mature let-7 mimic during reprogramming. As
expected, overexpressed let-7 resulted in fewer colonies (Fig-
ure 1D). As LIN-28 blocks let-7 processing (reviewed in Mayr
and Heinemann, 2013), we tested whether adding LIN-28 to
OSK during reprogramming would produce results equivalent
to reprogramming with OSK+let-7 inh. let-7 inhibition consis-
tently resulted in many more colonies than LIN-28 (Figures 1E
and 1F).
The let-7 Target LIN-41 Promotes iPSC Reprogramming
To understand the mechanism by which let-7 inhibition pro-
motes reprogramming, we sought to identify let-7 targets with
enhanced expression during reprogramming with OSK+let-7
inh. We tested several known let-7 targets, including HMGA2,
CDC34, and LIN-41, as well as RAS- and MYC-family genes
(Johnson et al., 2005; Kim et al., 2009; Kumar et al., 2007; Lee
and Dutta, 2007; Legesse-Miller et al., 2009; Mayr et al., 2007;
Melton et al., 2010; Sampson et al., 2007; Slack et al., 2000).
The levels of HMGA2, CDC34, LIN-41, and N-RAS increased
upon let-7 inhibition during OSK-induced reprogramming (Fig-
ure 2A), but we did not observe significant upregulation of the
MYC genes (Figures S3A–S3C).
We next testedwhether HMGA2, CDC34, LIN-41, and the RAS
genes alone or in combination could directly promote reprog-
ramming. Expressing a combination of HMGA2, CDC34, and
LIN-41 with OSK resulted in more colonies than did OSK alone,
while adding RAS-family proteins to this mix inhibited reprog-
ramming (Figure 2B). This is likely because N-RAS and H-RAS
inhibited reprogramming (Figure 2B).We found that LIN-41 alone
was responsible for the increased number of colonies, while the
others were dispensable (Figure 2B). Most colonies obtained
with OSK+LIN-41 (OSKL) had ES-like morphology, similar to col-
onies reprogrammed with OSK+let-7 inh (Figures 2C and S1C).
OSKL promoted reprogramming of MEFs but to a lesser extent
than it promotes reprogramming of HDFs (Figure S4A). In
contrast, expressing LIN-41 with OSKM did not significantly in-
crease reprogramming efficiency, although in most experiments
performed with HDFs, the number of colonies was slightly
increased (Figures 2D and S4A). LIN-41 expression during
reprogramming did not effect cell proliferation (Figure S5A).
These data indicate that the let-7 target gene LIN-41 increases
OSK-induced reprogramming efficiency. Furthermore, coloniesCell Stem Cell 14, 40–52, January 2, 2014 ª2014 Elsevier Inc. 41
Figure 1. let-7 Inhibition Is Necessary and Sufficient to Promote iPSC Reprogramming
(A) HDFs were treated with the indicated cocktails. Colonies with hESC-like morphology were counted and stained with TRA-1-60 antibody. Percent efficiency
was calculated by dividing by the number of cells reseeded on day 7. Data are represented as mean ± standard deviation (SD), n = 3.
(B) Pie graphs showing results from experiments with HDFs treated with either OSKM (left, n = 289 colonies total from three experiments) or OSK+let-7 inh (right,
n = 149 colonies total from three experiments). Colonies were counted and scored as having either hESC-like (green) or non-hESC-like (gray) morphology. Plates
were also stained with TRA-1-60 antibody to confirm the morphological scoring.
(C) Teratomas derived from OSK+let-7 inh reprogramming contain endoderm, ectoderm, and mesoderm.
(D and E) HDFs were treated with the indicated cocktails and ES-like colonies were counted per well. Data are represented as mean ± SD, n = 3.
(F) Representative TRA-1-60 staining of colonies treated with the indicated cocktails.
*p < 0.05. See also Figures S1 and S2.
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itive staining with pluripotencymakers, in vitro differentiation into
the three cellular lineages, the ability to form teratomas in vivo,
and their contribution to chimeric mice (Figures S2A–S2D and
S4B–S4F).
LIN-41 is abundantly expressed in iPSCs and ESCs but is
almost undetectable in fibroblasts (Chang et al., 2012; Rybak
et al., 2009). Therefore, we examined by quantitative (q) RT-
PCR whether endogenous LIN-41 expression was induced early
during reprogramming. At 5 and 7 days post-OSK infection, LIN-
41 mRNA levels were upregulated (Figures 2E and S5B). Inhibit-
ing let-7 during OSK-mediated reprogramming increased LIN-41
levels 3-fold compared to OSK alone. By day 7, when cells were
reprogrammed with the OSKM cocktail, LIN-41 expression was
even further increased to about 5-fold higher levels compared to
OSK. At these levels, LIN-41 function may be nearly saturated
andmay explain why the addition of LIN-41 to theOSKMcocktail42 Cell Stem Cell 14, 40–52, January 2, 2014 ª2014 Elsevier Inc.did not substantially increase the number of colonies (Figure 2D).
Additionally, LIN-41 upregulation occurs prior to let-7 downregu-
lation (data not shown and Figure S5C). These data suggest that
transfecting let-7 inh with OSK helps overcome the let-7 barrier
to reprogramming and boosts LIN-41 expression levels toward
those achieved by OSKM.
We next sought to determine if the endogenous LIN-41 levels
induced by OSK+let-7 inh and OSKM were comparable to the
exogenous LIN-41 levels expressed by retrovirus. The LIN-41
retrovirus efficiently expresses LIN-41 protein, as assessed by
examination of the mixed population of HDFs and reprogram-
ming cells (Figure S5D). Since only a small fraction of the cell
population will become iPSCs, we examined LIN-41 expression
in individual cells by immunofluorescence (Figure 2F). First, we
scored DAPI-stained cells as LIN-41-positive or -negative. As
expected, the LIN-41 retrovirus infects 25% of HDFs, which
is five to seven times more cells than express endogenous
Figure 2. The let-7 Target LIN-41 Promotes Reprogramming with OSK
(A) Representative western blots of the indicated factors at day 13 after infection with GFP, OSK+control inh, OSK+let-7 inh, or OSKM.
(B) HDFs were treated with OSK plus the indicated factors and scored for the number of ES-like colonies. Data are represented as mean ± SD, n = 3.
(C) Pie graph showing the result from experiments of HDFs treatedwith OSKL (n = 799 colonies total from five experiments). Colonies were counted and scored as
having either hESC-like (green) or non-hESC-like (gray) morphology. Plates were also stained with TRA-1-60 antibody to confirm the morphological scoring.
(D) HDFs were treated with the indicated factors and ES-like colonies were counted. Data are represented as mean ± SD, n = 10.
(E) qRT-PCR results for LIN-41 after 7 days of treatment with the indicated factors. Data are represented as mean ± SD, n = 3.
(F) Representative immunofluorescence images of cells 8 days postinfection with the indicated factors. Green, LIN-41; red, OCT4, blue, DAPI stain for nuclei.
Scale bars, 10 mm.
*p < 0.05, **p < 0.01, n.s., not significant. See also Figures S1-S5.
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plus either let-7 inh orM (Figure S5E). Next, to determinewhether
the LIN-41 levels in individual cells were comparable among the
OSK+let-7 inh, OSKM, and OSKL cocktails, we quantified fluo-
rescence intensity in individual cells that expressed LIN-41.
The level of retroviral LIN-41 was variable, as expected (Fig-
ure S5F). We found that many cells transduced with OSK+let-7
inh and OSKM cocktails expressed a level of endogenous LIN-
41 that was similar to the level of LIN-41 produced by LIN-41
retrovirus (Figure S5F). These data suggest that LIN-41 levels re-
sulting from let-7 inhibition would likely be sufficient to promote
reprogramming in a manner similar to LIN-41 retrovirus.
Multiple Domains of LIN-41 Contribute to
Reprogramming Activity
LIN-41 is a member of the RING, B-box, Coiled-coil (RBCC)
family of proteins, which contain a RING domain, two B-box
domains, a Coiled-coil domain, a filamin domain, and six NHL
repeats (Figure 3A). To identify LIN-41 domains that facilitate
reprogramming, we generated HA-tagged domain deletion mu-
tants (DRING, DB-boxes, DCoiled-coil, DFilamin, D6xNHL, and
NHL-only) and expressed them in HDFs (Figures 3A and 3B).
We found that wild-type LIN-41 (wtLIN-41) and the DRING
mutant had similar patterns of intracellular localization, though
expression of the DRING mutant altered fibroblast morphology,
imparting a less elongated shape (Figure 3C). Each of the other
deletion mutants displayed altered cellular localization patterns
(Figure 3C), which may contribute to their differing effects on
reprogramming: we found that expression of OSK plus each
domain mutant resulted in fewer colonies than OSK+wtLIN-41.
DRING, D6xNHL, and NHL-only mutants produced the
fewest colonies (Figure 3D and 3F). When DRING was added
to OSKM, reprogramming was strongly inhibited (Figures 3E
and 3F). Adding the other domain mutants to OSKM did not
change the number of colonies (Figure 3E).
LIN-41 has been shown to have E3 ubiquitin ligase activity
(Chen et al., 2012; Rybak et al., 2008). The RING domain of E3
ubiquitin ligases interacts with E2 ubiquitin-conjugating enzymes
and ubiquitin, which are critical for proteasome-mediated degra-
dation. Seven cysteines and a histidine residue in the RING
domain coordinate the zinc molecules important for maintaining
the structure and function of the domain (Deshaies and Joazeiro,
2009;Plechanovova´ et al., 2012;Rybaket al., 2009). Todetermine
if E3 ubiquitin ligase activity is important for LIN-41-mediated re-
programming, we made cysteine-to-alanine (C to A) point muta-
tions within the RING domain (Figures 3A–3C). Mutating the first
two cysteines of this domain disrupts LIN-41’s E3 ubiquitin ligase
activity (Rybak et al., 2009). Surprisingly, unlike DRING, when we
expressed OSK with either of the C to A point mutants, we ob-
tained a similar number of colonies as when reprogramming
with wtLIN-41 (Figures 3D–3F). These data suggest that LIN-
41’s function in reprogramming is independent of cysteine-medi-
atedzinccoordinationandE3ubiquitin ligaseactivity.Constitutive
high expression ofDRING in human ESCs (hESCs) resulted in cell
death, suggesting thatDRING is toxic (data not shown), making it
difficult to ascribe a role for the RING domain to reprogramming.
Recent reports implicate LIN-41 in the regulation of multiple
signaling pathways, including those mediated by Ago2 (Rybak
et al., 2008), FGF (Chen et al., 2012), and mouse ESC prolifera-44 Cell Stem Cell 14, 40–52, January 2, 2014 ª2014 Elsevier Inc.tion through the p21/Cdkn1a pathway (Chang et al., 2012).
We did not observe changes in the levels of AGO2 or FGF
signaling mediators upon LIN-41 and DRING expression during
reprogramming or LIN-41 knockdown in hESCs (Figures S6A–
S6C). The expression of p21, a negative regulator of reprogram-
ming, is upregulated during OSKM-mediated reprogramming
(reviewed in Banito and Gil, 2010). If p21 were downstream of
LIN-41 in reprogramming, we would expect LIN-41 and DRING
to affect p21 levels differentially, as LIN-41 promotes reprogram-
ming while DRING inhibits it. While we did observe a reduction in
p21 levels upon LIN-41 expression with OSKM, we saw a similar
decrease when DRING was expressed (Figure S6D). Adding
LIN-41 or DRING to OSK did not affect p21 levels (Figure S6D).
These data suggest that p21 is not likely the downstream
effector of LIN-41 for reprogramming.
LIN-41 Induction Is Important for Overcoming the let-7
Barrier to iPSC Reprogramming
To determine if LIN-41 activity is important for reprogramming,
we knocked down LIN-41 expression during reprogramming
by transfecting cells with one of two siRNAs that target LIN-41.
Transfecting these siRNAs into hESCs reduced LIN-41 levels
but did not affect colony morphology (Figures 4A, 4B, and
S6E), suggesting that LIN-41 knockdown does not affect plurip-
otency. This is consistent with studies of Lin-41 knockout mice,
which display defects in neural tube closure and death between
embryonic days (E) E8.5–E13.5 (Chen et al., 2012; Maller Schul-
man et al., 2008). In contrast, we found that knocking down LIN-
41 during reprogramming with OSK+let-7 inh resulted in fewer
colonies (Figures 4C and 4D). Therefore, endogenous LIN-41 is
an important target of let-7 that needs to be upregulated for
let-7 inhibition to promote reprogramming.
To test if LIN-41 is the only let-7 target gene important for
reprogramming, we compared the efficiency of reprogramming
with OSK, OSKL, OSK+let-7 inh, and OSKL+let-7 inh. Retroviral
LIN-41 only contains the open reading frame and therefore lacks
the let-7 binding sites that regulate endogenous LIN-41 expres-
sion. OSKL and OSK+let-7 inh resulted in comparable colony
numbers (Figure 4E), while combining OSKL with let-7 inh further
enhanced the number of colonies (Figure 4E). Thus, there are
likely additional let-7 targets that contribute to reprogramming.
We wanted to determine if LIN-41 expression could overcome
the let-7 barrier to reprogramming. First, we confirmed that sus-
tained let-7 levels repress endogenous LIN-41 (Figure 4F). When
wereprogrammedwithOSKM+GFPorOSKM+LIN-41 in thepres-
enceof let-7mimic,more colonieswere obtainedwithLIN-41 than
withGFP (Figures1Dand4G). Asa controlwe testedGLIS1, a fac-
tor that increasesOSKMreprogrammingefficiency (Figure4Gand
Maekawa and Yamanaka, 2011). Overexpressed LIN-41 was
more effective at restoring the number of colonies in the presence
of let-7mimic than was GFP or GLIS1 (Figure 4H). Additional let-7
targets must also contribute to overcoming the let-7 barrier to re-
programming, as LIN-41 does not completely restore the number
of colonies to that obtained with control mimic. These data indi-
cate that LIN-41 can partially rescue the deficit in reprogramming
when let-7 levels are high. Therefore, we have identified LIN-41 as
a targetof let-7 regulation that is increasedduring reprogramming,
promotes reprogramming, and is important for surmounting the
let-7 barrier to reprogramming.
Figure 3. All Domains of LIN-41 Contribute to Reprogramming
(A) Diagram of the domain structure of LIN-41 and the domain deletion and point mutants constructed. C12AC15A contains alanines in the place of cysteines at
positions 12 and 15 of the human LIN-41 open reading frame. 7CtoA contains alanines in place of cysteines at positions 12, 15, 61, 66, 69, 91, and 94.DRING lacks
amino acids 12–91.DB-box lacks amino acids 194–320.DCoiled-coil lacks amino acids 328–447.DFilamin lacks amino acids 483–583.D6xNHL lacks amino acids
593–868. NHL-only contains only an initiating methionine and amino acids 583–868. The white asterisks indicate the position of C to A point mutations.
(B) Representative western blot showing the levels of HA-tagged wtLIN-41 and domain deletion mutants expressed in HDFs.
(C) Representative immunofluorescence images of HA-tagged wtLIN-41 and domain deletion mutants expressed in HDFs. Green, HA tag; blue, DAPI stain for
nuclei. Scale bars, 10 mm.
(D) HDFs were treated with OSK plus the indicated factors and ES-like colonies were counted. In the right graph, a construct with additional C to A mutations
(7CtoA) was tested for reprogramming ability. Data are represented as mean ± SD, n = 3.
(E) The same type of experiment as in (D) but with OSKM. Data are represented as mean ± SD, n = 3.
(F) Representative TRA-1-60 staining of colonies treated with the indicated cocktails.
*p < 0.05, **p < 0.01.
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Figure 4. LIN-41 Is Important for Overcoming the let-7 Barrier to Reprogramming
(A) Representative western blots of H9 hESCs 72 hr after transfection with control or LIN-41 siRNAs.
(B) Representative images of H9 hESCs 72 hr after transfection with control or LIN-41 siRNAs.
(C) HDFs were treated with OSK plus control or let-7 inh and transfected with control or LIN-41 siRNAs and ES-like colonies were counted. Data are represented
as mean ± SD, n = 3.
(D) Representative TRA-1-60 staining of colonies treated with OSK plus the indicated factors.
(E) HDFs were treated with the indicated factors and ES-like colonies were counted. Data are represented as mean ± SD, n = 4.
(F) qRT-PCR for LIN-41 after 7 days of treatment with the indicated cocktails. Data are represented as mean ± SD, n = 3.
(legend continued on next page)
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Figure 5. LIN-41 Knockdown Alters Expression of Genes Involved in Development and Differentiation, Including the Transcription Factor
EGR1
(A) Representative western blots for LIN-41, EGR1, and GAPDH, 72 hr after H1 hESCs were transfected with control or LIN-41 siRNAs.
(B) List of the most significantly upregulated (left) and downregulated (right) transcripts upon LIN-41 knockdown, as assayed by RNaseq.
(C) List of the top biological processes enriched among genes altered upon LIN-41 knockdown.
(D) List of the top TFs with enriched predicted binding sites among genes altered upon LIN-41 knockdown. Among these TFs, only EGR1 had altered expression
when LIN-41 was knocked down.
(E) List of the top biological processes enriched among genes with predicted EGR1 binding sites among genes altered upon LIN-41 knockdown.
See also Figure S6, Table S1, and Table S2.
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To gain insight into the mechanism by which LIN-41 promotes
reprogramming, we first knocked down LIN-41 expression in(G) HDFs were treated with the indicated cocktails and transfected with either con
Data are represented as mean ± SD, n = 3.
(H) The mean number of colonies obtained in wells transfected with let-7 mimic
was divided by the mean number of colonies obtained in wells transfecte
percentages ± SD, n = 3.
*p < 0.05, n.s., not significant.hESCs by 90% and examined genome-wide transcriptome
changes by RNAseq. Expression of over 1,000 genes was
altered (Figure 5A, 5B, and Table S1). Gene ontology (GO)trol (gray bars) or let-7 (black bars) mimic, and ES-like colonies were counted.
for each indicated reprogramming cocktail (OSKM+GFP, LIN-41, or GLIS1)
d with control mimic and the same reprogramming cocktail. Values are
Cell Stem Cell 14, 40–52, January 2, 2014 ª2014 Elsevier Inc. 47
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ferentiation (Figure 5C). We hypothesized that LIN-41 may pro-
mote reprogramming by regulating a broadly acting transcription
factor. To test this, we used Whole Genome rVISTA (Dubchak
et al., 2013) to search for predicted transcription factor (TF) bind-
ing sites that are enriched within the set of genes regulated by
LIN-41. One TF, EGR1, stood out, as its transcript was also
among those most upregulated upon LIN-41 knockdown (Fig-
ures 5B and 5D). We found that EGR1 protein expression was
also upregulated upon LIN-41 knockdown (Figure 5A).
GOanalysis of thesubsetof geneswithpredictedEGR1binding
sites indicated an enrichment of genes involved in development
and differentiation, as well as phosphorylation (Figure 5E). EGR1
has been shown to promote differentiation when expressed in
embryonal carcinoma cells, which are similar to ESCs, and to
regulatedifferentiation in various contexts (Caoet al., 1990;Carter
et al., 2007; Dinkel et al., 1998; Edwards et al., 1991; Harris and
Horvitz, 2011; Krishnaraju et al., 1995; Lanoix et al., 1998; Laslo
et al., 2006; Le et al., 2005; Lejard et al., 2011; Nguyen et al.,
1993; Spaapen et al., 2013; Sukhatme et al., 1988; Topilko
et al., 1998; Zhang et al., 2013). Fragola et al. (2013) proposed
that EGR1 functions as a key TF thatmaintains the fibroblast tran-
scriptional profile. Of the geneswe identifiedwith predictedEGR1
bindingsites, several havebeenpreviouslyvalidatedbychromatin
immunoprecipitation as EGR1 targets in cancer cells by the
ENCODE project (Table S2). One of the predicted targets that
has also been validated as an EGR1 target is NAB2. NAB2 is not
only a target of EGR1 regulation, but also acts as a corepressor
or coactivator of EGR1 activity, depending on cellular context
(Collins et al., 2006; Kumbrink et al., 2010; Sevetson et al., 2000;
Svaren et al., 1996). Both EGR1 and NAB2 are induced by mito-
genic stimuli, including serum and purified factors such as FGF
(Svaren et al., 1996; reviewed in Gashler and Sukhatme, 1995).
During reprogramming, serumand FGF are replenished on a daily
basis (serum on reprogramming days 1–8 and FGF thereafter),
thus stimulating expression of these differentiation-associated
genes (data not shown). Therefore, our data suggest that LIN-41
has a role in overcoming this differentiation barrier.
We next examined the effect of LIN-41 on endogenous EGR1
expression on a single-cell basis by infecting cells with HA-LIN-
41 or GFP retrovirus, performing immunofluorescence staining
with EGR1 and HA antibodies, and quantitating EGR1 fluores-
cence intensity in individual cells (Figure 6A). We found that LIN-
41 expression repressed EGR1 protein expression (Figure 6B).
These findings were corroborated by examining EGR1 mRNA
expression in isolated TRA-1-60+ reprogramming cells. EGR1
was repressed the most when the OSKL cocktail was used,
compared to the OSK, OSK+let-7 inh, and OSKM cocktails (Fig-
ure S6F). These data support a recent report showing that EGR1
is downregulated in mouse reprogramming and acquires the
repressive histone modification H3K27me3 (Fragola et al., 2013).
Supporting our finding that predicted EGR1 binding sites were
enriched among genes with altered expression upon LIN-41
knockdown, predicted EGR1 binding sites were also enriched
among the genes with a greater than 3-fold difference in expres-
sion between the OSKL and OSK cocktails (Figure S6F). In
addition, of the top 10 enriched TFs, EGR1 was the only factor
significantly downregulated in OSKL reprogramming cells.
(Figure S6G).48 Cell Stem Cell 14, 40–52, January 2, 2014 ª2014 Elsevier Inc.Corroborating our finding with LIN-41 knockdown, biological
processes related to development and differentiation were also
enriched among genes with predicted EGR1 binding sites in
OSKL reprogramming cells (Figure 6C). Based on the above find-
ings, we theorized that EGR1 expression is another barrier that
needs to be overcome during reprogramming. To test this, we
overexpressed EGR1 with the OSKL cocktail (Figure 6D). This
generated fewer colonies than OSKL but more than OSK+GFP
(Figures 6E and S6H), indicating that overexpression of EGR1
negates LIN-41’s positive effect on reprogramming.
Finally, we wanted to determine if LIN-41 regulates EGR1
expression directly by binding to the EGR1 transcript. We immu-
noprecipitated (IP’d) endogenous LIN-41 from hESCs using a
LIN-41 antibody. We performed side-by-side IPs in which the
antibody was either free to bind endogenous LIN-41 or blocked
by preincubation with the peptide antigen (Figure 6F). We
collected RNA from the IPs and compared enrichment of
EGR1 mRNA and control mRNAs GAPDH and OCT4 between
the LIN-41 IPs and peptide-blocked IPs. We found that EGR1
mRNA, but not GAPDH or OCT4 mRNA, was enriched when
LIN-41 was IP’d (Figure 6G). Collectively, these data suggest
that one role of LIN-41 in reprogramming is to lower EGR1 levels
and thereby dysregulate genes associated with differentiation.
DISCUSSION
In this study, we found that the let-7 family of miRNAs acts as a
barrier to reprogramming via a pathway that promotes the
expression of prodifferentiation genes. We found that inhibiting
let-7 with the OSK cocktail increases the reprogramming effi-
ciency of HDFs to a level comparable to that seen with OSKM.
In addition, we established that let-7 inhibition enhances OSK-
mediated reprogramming, at least in part through promoting
LIN-41 expression. Exogenous LIN-41 expression promotes
reprogramming with OSK, while knocking down endogenous
LIN-41 expression reduces the formation of iPSC colonies.
Furthermore, we found that LIN-41 expression is upregulated
during reprogramming with OSK+let-7 inh, as well as with
OSKM, indicating that antagonizing let-7 helps to increase
LIN-41 levels and consequently, the reprogramming power of
the otherwise inefficient OSK cocktail. LIN-41 can also partially
overcome the negative effect of let-7 expression on reprogram-
ming. Finally, we found that EGR1 mRNA is bound and nega-
tively regulated by LIN-41 and acts to block reprogramming.
Analysis of the genes with predicted EGR1 binding sites and
altered expression upon LIN-41 knockdown or LIN-41 expres-
sion during reprogramming link LIN-41 to regulation of develop-
ment and differentiation. Therefore, we have characterized a
pathway in which antagonizing let-7 results in upregulation of
let-7 targets including LIN-41, which in turn inhibits expression
of prodifferentiation factors such as EGR1.
LIN-41 is a conserved target of let-7 regulation (Lin et al., 2007;
O’Farrell et al., 2008; Rybak et al., 2009; Schulman et al., 2005;
Slack et al., 2000). lin-41 and let-7 were identified in C. elegans
as heterochronic genes, whereby overexpression of let-7 or dele-
tion of lin-41 resulted in precocious differentiation into adult cell
fates, and deletion of let-7 or overexpression of lin-41 led to the
reiteration of larval cell fates (Reinhart et al., 2000; Slack et al.,
2000). We demonstrate that the let-7/LIN-41 pathway also
Figure 6. EGR1 Is a Target of LIN-41 that Blocks Reprogramming
(A) HDFs were infected with HA-LIN-41 or GFP retroviruses and immunostained with anti-HA and anti-EGR1 at 8 days postinfection. Arrowheads indicate EGR1+
cells. Scale bars, 10 mm.
(B) We selected random fields of DAPI-stained nuclei and captured images in the blue (DAPI), green (LIN-41 or GFP), or red (EGR1) channels. The level of EGR1
fluorescence intensity was measured using Volocity (PerkinElmer). Cells were scored as having fluorescence intensity above (high) or below (low) a threshold.
Values are the mean of the percent of infected cells with high EGR1 expression ± SD, andR50 cells were scored for each condition in each experiment. n = 3.
(C) List of the top biological processes enriched among genes with EGR1 binding sites and a greater than three-fold difference between OSKL and OSK re-
programming cells.
(D) Representative western blots for LIN-41, EGR1, and GAPDH at 7 days postinfection with the indicated cocktails.
(E) HDFs were treated with the indicated factors and ES-like colonies were counted. Data are represented as mean ± SD, n = 3.
(F) Representative western blot for LIN-41. Beads bound to LIN-41 antibody or LIN-41 antibody preincubated with peptide antigen were used in IP experiments
with hESC extract.
(G) qRT-PCR was performed with RNA collected from the LIN-41 IPs and peptide-blocked IPs. Data are represented as mean ± SD, n = 3.
*p < 0.05, **p < 0.001. See also Figure S6.
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heterochronic gene, did not phenocopy let-7 inh and LIN-41 in
promoting reprogramming with OSK. However, LIN-28 has
been shown to play a role in reprogramming (Hanna et al., 2009;
Yu et al., 2007), suggesting that a let-7-independent function of
LIN-28maybe involved (reviewed inMayr andHeinemann, 2013).
Another interesting link to the heterochronic pathway is our
finding that LIN-41 regulates EGR1 expression and that EGR1
blocks reprogramming. The C. elegans heterochronic gene
MAB-10 is an ortholog to the EGR1 cofactors NAB1 and
NAB2 (Harris and Horvitz, 2011). MAB-10 interacts with another
heterochronic gene, LIN-29, via a LIN-29 domain that is
conserved in EGR proteins (Harris and Horvitz, 2011). The
timing of LIN-29 expression is regulated by LIN-41, although
the mechanism by which LIN-41 regulates LIN-29 remains
unknown (Slack et al., 2000). In mammals, EGR1 has been
shown to regulate differentiation and development in several
contexts (Cao et al., 1990; Carter et al., 2007; Dinkel et al.,
1998; Edwards et al., 1991; Krishnaraju et al., 1995; Laslo
et al., 2006; Le et al., 2005; Lejard et al., 2011; Nguyen et al.,
1993; Spaapen et al., 2013; Sukhatme et al., 1988; Topilko
et al., 1998; Zhang et al., 2013), and expression of EGR1
in P19 embryonal carcinoma cells resulted in spontaneous
differentiation (Lanoix et al., 1998). EGR1 is an early growth
response gene that is induced by mitogenic stimuli, including
serum and purified factors such as FGF, EGF, and TGFb
(reviewed in Gashler and Sukhatme, 1995). As EGR1 is
expressed in HDFs and induced by such stimuli present in
the cell culture medium, it is logical that EGR1 expression
would need to be downregulated for reprogramming to occur.
Future studies to address the mechanism by which LIN-41
regulates translation and to understand how it recognizes partic-
ular transcripts will help to further elucidate the role of LIN-41 in
regulating differentiation pathways.
EXPERIMENTAL PROCEDURES
Cell Culture and Reprogramming
Cells were maintained using standard methods (described in the
Supplemental Experimental Procedures). HDFs from Cell Applications
were used in this study (lots 1429, 1323, and 1503). Reprogramming
was carried out with retroviruses as described (Takahashi et al., 2007).
Seven days postinfection, the cells were trypsinized, counted, and reseeded
onto SNL feeders at 2 3 104 or 5 3 104 per well for reprogramming with
or without c-MYC, respectively. Cells were transfected with miRNA inh
(20 nM, Dharmacon, control inh [IN-001005-01] or let-7c inh [IH-300477-05])
(Robertson et al., 2010) on days 1, 6, 12, 18, and 24 unless otherwise indicated.
Cells were transfected with siRNAs (20 nM) every 3 days starting on day 2.
Western Blotting
Primary antibodies are listed in Table S3. Li-Cor secondary antibodies were
used and blots were scanned using an Odyssey Fc.
Knockdowns
siRNAs fromAmbion (TRIM71: s43598ands43599,NegativeControl 1:4390844)
were transfected using Lipofectamine RNAimax (Life Technologies) at 20 nM
final concentration for reprogramming or 50 nM for knockdowns in hESCs.
Immunofluorescence
Primary antibodies are listed in Table S3. Alexa Fluor secondary antibodies
(Life Technologies) were used at a 1:200 dilution. The staining protocol is
described in the Supplemental Experimental Procedures.50 Cell Stem Cell 14, 40–52, January 2, 2014 ª2014 Elsevier Inc.LIN-41 IP
LIN-41 IPs were performed using hESC extract and LIN-41 monoclonal anti-
body (peptide antigen: CVRAHQRVRLTKDHYIER; developed in collaboration
with Epitomics). Dynabeads with captured anti-LIN-41 were either left free
to bind LIN-41 or first blocked with 3X-LIN-41 peptide (NH2-
RVRLTKDHYIERRVRLTKDHYIERRVRLTKDHYIER-COOH) to block the LIN-
41 antibody binding sites. RNA was collected and analyzed by qRT-PCR.
Additional details are in the Supplemental Experimental Procedures.
qRT-PCR
Trizol-extracted RNA was reverse-transcribed using Superscript III (Life
Technologies) and random priming. Taqman assays were performed (probes
are listed in Table S3). Gene expression was normalized to GAPDH.
Transcriptome Analyses
TRA-1-60+ cells on reprogramming day 11 were isolated and analyzed as
described previously (Tanabe et al., 2013). Gene expression upon LIN-41
knockdownwas analyzed by Illumina HiSeq 2000 and as described in the Sup-
plemental Experimental Procedures. We analyzed genes with differential
expression (FDR < 0.05) between the control siRNA samples (n = 3) and the
LIN-41 siRNA samples (n = 6) using GO-Elite (http://www.genmapp.org/
go_elite/; Zambon et al., 2012). We performed a similar analysis between
TRA-1-60+ OSKL versus OSK reprogramming cells. We used Whole Genome
rVISTA (Dubchak et al., 2013) to identify enriched predicted TF binding sites
among these gene sets.
Cloning
The LIN-41 cDNA was obtained from Thermo (clone 610064) and the EGR1
cDNA from GeneCopoeia (clone GC-0600487). These and the LIN-41 domain
and point mutants were cloned into the retroviral expression vector pMXs.
Oligos and cloning methods are described in Table S3 and the Supplemental
Experimental Procedures.
Statistical Analysis
Values are means ± standard deviation unless otherwise indicated. Signifi-
cance was determined with Student’s t tests.
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